[Hyderabad, April 21st, 2025] – The Global Artificial Insemination Market, valued at USD 2.1 billion in 2023, is projected to grow at a CAGR of 9.2%, reaching USD 4.3 billion by 2031. This growth is driven by rising infertility rates and livestock genetic optimization, according to ClearView Market Insights.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-artificial-insemination-market/
2024 Key Advances
- Human AI: Vitrolife’s AI sperm selection boosts pregnancy rates by 22%.
- Livestock AI: STgenetics’ SexedULTRA™ achieves 95% gender selection accuracy.
- At-Home Testing: FDA clears first AI-powered semen analyzer for home use.
Regional Leaders
- North America (35%) – Leading in IVF & precision livestock breeding.
- Europe (XX%) – Strict regulations ensure high-quality AI solutions.
- Asia-Pacific (XX%) – Fastest-growing due to rising infertility awareness.
Executive Insights
"AI is no longer just a backup option—it’s becoming the first choice for fertility and livestock breeding."
— Dr. Sarah Jensen, CooperSurgical Reproductive Health VP
Roadmap to 2031
- 2025: 40% of IVF clinics to adopt AI-based sperm selection.
- 2027: Gene-edited livestock semen enters commercial use.
- 2030: At-home AI kits to capture 20% of fertility testing market.
For more insights, visit https://clearviewmarketinsights.com/report-store
About ClearView Market Insights
We analyze 90+ healthcare and agri-tech markets, from fertility to livestock genetics.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
